Recurrence-free or progression-free survival as a surrogate endpoint for overall survival in hepatobiliary-pancreatic cancers: would be associated with time change
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1047-1050.
doi: 10.21037/hbsn-24-597.
Epub 2024 Nov 21.